Overview and Scope
Cell culture media refer to nutrient-rich solutions designed to support the growth, maintenance, and proliferation of cells outside of their natural environment. They typically contain a balanced mixture of amino acids, vitamins, minerals, sugars, and growth factors tailored to specific cell types. Media composition can vary widely depending on the cell’s requirements and experimental objectives.
Sizing and Forecast
The cell culture media market size has grown rapidly in recent years. It will grow from $4.84 billion in 2023 to $5.46 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to growing research and development (R&D) activities, rising prevalence of chronic diseases, expansion of the biopharmaceutical industry, supportive government initiatives and funding, and growing demand for regenerative medicine and stem cell therapies.
The cell culture media market size is expected to see rapid growth in the next few years. It will grow to $8.91 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to an increasing focus on personalized medicine, a growing pipeline of biopharmaceutical products, expansion of stem cell research, increasing adoption of organ-on-a-chip technology for drug testing and toxicity screening, growing healthcare infrastructure, rising investments in life sciences research, and expanding biopharmaceutical manufacturing capabilities. Major trends in the forecast period include technological advancements in biotechnology, the emergence of cell and gene therapies, the adoption of organ-on-a-chip technology for drug testing and toxicity screening, the adoption of animal-free and chemically-defined cell culture media formulations, integration of advanced cell culture systems, microfluidics, and bioreactor technologies.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-culture-media-global-market-report
Segmentation & Regional Insights
The cell culture media market covered in this report is segmented –
1) By Type: Liquid Media, Semi-solid And Solid Media
2) By Product: Serum Free Media, Classical Media, Stem Cell Culture Media, Specialty Media, Chemically Defined Media, Other Cell Culture Media
3) By Application: Biopharmaceutical Production, Diagnostics, Drug Screening And Development, Tissue Engineering And Regenerative Medicine, Other Applications
4) By End User: Biotechnology And Pharmaceutical Industry, Academic Institute, Research Laboratory, Other End Users
North America was the largest region in the cell culture media market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell culture media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14871&type=smp
Major Driver Impacting Market Growth
The increase in the manufacturing of pharmaceutical drugs is expected to propel the cell culture media market going forward. Pharmaceutical drugs refer to medications or substances used for the prevention, treatment, or diagnosis of medical conditions in humans or animals. The surge in pharmaceutical drug manufacturing can be attributed to the increased prevalence of chronic and infectious diseases and the growing aging population, which necessitates a higher demand for medications to manage age-related conditions and ailments. Cell culture media provide the essential nutrients and environment for the growth and maintenance of cells used in pharmaceutical drug manufacturing, ensuring optimal cell growth and the production of desired therapeutic proteins or molecules. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based European trade association representing the pharmaceutical industry, the total bio-pharmaceutical production in Europe accounted for $384,200 million (€340,000 million) in 2022, an increase of approximately 4.95% from $366,267 million (€323,950 million) in 2021. Therefore, the increase in the manufacturing of pharmaceutical drugs is driving the growth of the cell culture media market.
Key Industry Players
Major companies operating in the cell culture media market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Sartorius AG, CYTIVA Lifesciences, Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Takara Bio, MP Biomedicals, FUJIFILM Irvine Scientific Inc., Promocell Inc., InSphero AG, PeproTech Inc., HiMedia Laboratories Pvt. Ltd., Elabscience Biotechnology Inc., Capricorn Scientific GmbH, CAISSON Laboratories Inc., Cell Biologics Inc., Nucleus Biologics LLC
The cell culture media market report table of contents includes:
1. Executive Summary
2. Cell Culture Media Market Characteristics
3. Cell Culture Media Market Trends And Strategies
4. Cell Culture Media Market – Macro Economic Scenario
5. Global Cell Culture Media Market Size and Growth
…
32. Global Cell Culture Media Market Competitive Benchmarking
33. Global Cell Culture Media Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Culture Media Market
35.Cell Culture Media Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
